PTH and hyperparathyroidism: Hence, current guidelines state that it is reasonable to reserve the use of calcitriol and active vitamin D compounds for patients with advanced CKD and severe and progressive hyperparathyroidism [83] although more targeted PTH control during non-dialysis-CKD period may influence outcomes during HD [84].